Abstract

ABCG2 is an ATP binding cassette (ABC) half-transporter that plays a key role in multidrug resistance to chemotherapy. ABCG2 is believed to be a functional homodimer that has been proposed to be linked by disulfide bridges. We have investigated the structural and functional role of the only three cysteines predicted to be on the extracellular face of ABCG2. Upon mutation of Cys-592 or Cys-608 to alanine (C592A and C608A), ABCG2 migrated as a dimer in SDS-PAGE under non-reducing conditions; however, mutation of Cys-603 to Ala (C603A) caused the transporter to migrate as a single monomeric band. Despite this change, C603A displayed efficient membrane targeting and preserved transport function. Because the transporter migrated as a dimer in SDS-PAGE, when only Cys-603 was present (C592A-C608A), the data suggest that Cys-603 forms a symmetrical intermolecular disulfide bridge in the ABCG2 homodimer that is not essential for protein expression and function. In contrast to C603A, both C592A and C608A displayed impaired membrane targeting and function. Moreover, when only Cys-592 or Cys-608 were present (C592A/C603A and C603A/C608A), the transporter displayed impaired plasma membrane expression and function. The combined mutation (C592A/C608A) partially restored plasma membrane expression; however, although transport of mitoxantrone was almost normal, we observed impairment of BODIPY-prazosin transport. This supports the conclusion that Cys-592 and Cys-608 form an intramolecular disulfide bridge in ABCG2 that is critical for substrate specificity. Finally, mutation of all three cysteines simultaneously resulted in low expression and no measurable function. Altogether, our data are consistent with a scenario in which an inter- and an intramolecular disulfide bridge together are of fundamental importance for the structural and functional integrity of ABCG2.

Highlights

  • IntroductionThe resistant tumor cells often overexpress one of several ATP binding cassette (ABC) transporters that are capable of mediating efflux of clinically important drugs [1]

  • Multidrug resistance represents a serious problem in cancer chemotherapy

  • We have previously proposed that ABCG2 is a structural and functional homodimer and that this dimer is disrupted by the addition of DTT in the loading buffer prior to analysis by SDS-PAGE [24]

Read more

Summary

Introduction

The resistant tumor cells often overexpress one of several ATP binding cassette (ABC) transporters that are capable of mediating efflux of clinically important drugs [1]. One of these is ABCG2, known as MXR, ABCP, and BCRP [2,3,4]. Many ABC halftransporters function as homo- or heterodimers [18, 19], and it is widely accepted that ABCG2 exists as a homodimer (20 –22). Our previous studies have supported that ABCG2 is an oligomer (most likely a homodimer), and function of the transporter is dependent on this dimerization [24]. We have carried out a systematic mutagenesis analysis of these cysteines to assess their role in the structure and covalent linking of the ABCG2 homodimer

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.